CC-401

Based on 20 reference(s) in Google Scholar 80 100 20

Axon 2025

CAS [395104-30-0]

MF C22H24N6O
MW 388.47

CC-401

Description

A second generation ATP-competitive c-Jun N terminal kinase (JNK) inhibitor with potential antineoplastic activity.

Apoptosis Cell Signaling & Oncology Immunology Pain & Inflammation MAPK (JNK) p53-Tumor Suppression NF-κB MAPK EC 2.7.11.24

ATP-competitive JNK inhibitor

3-(3-(2-(piperidin-1-yl)ethoxy)phenyl)-5-(1H-1,2,4-triazol-5-yl)-1H-indazole

[395104-30-0]

Order

Size	Unit Price	Stock
5 mg	€120.00	In Stock
25 mg	€480.00	In Stock

Need more? Bulk Inquiry

Axon ID	Name	Description
1291	AEG 3482	JNK inhibitor	€90.00
2002	Bentamapimod	JNK inhibitor, which inhibited JNK1, JNK2 and JNK3	€70.00
2361	JNK-IN-8	Remarkably potent and selective covalent inhibitor of JNK	€95.00
2365	SR 3576	Very potent JNK3 inhibitor with >2800-fold selectivity over p38	€135.00
2519	SP 600125	Selective, reversible, and ATP-competitive JNK inhibitor	€70.00
2634	CC-930	Potent, selective, and orally active anti-fibrotic JNK inhibitor	€95.00
2949	JNK inhibitor VIII	Selective, ATP-competitive, and cell-permeable JNK inhibitor	€105.00
3625	GNE-3511	Potent, selective, orally bioavailable and brain-penetrant DLK inhibitor	€90.00